Mastacchi R et al. |
Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets. |
1986 |
Agents Actions |
pmid:3518359
|
Kantar A et al. |
Effect of PAF on human lymphocyte membranes: a fluorescence study. |
1993 |
Agents Actions |
pmid:8317302
|
Boonen GJ et al. |
Activation of neutrophil migration by dioctanoyl-sn-glycerol and fMet-Leu-Phe is controlled by different pathways. |
1993 |
Agents Actions |
pmid:8317308
|
Jouvin-Marche E et al. |
Platelet-activating factor (PAF-acether), an activator of neutrophil functions. |
1982 |
Agents Actions |
pmid:6299078
|
Caillard CG et al. |
Hypotensive activity of PAF-acether in rats. |
1982 |
Agents Actions |
pmid:6299079
|
Czarnetzki BM and Benveniste J |
Effect of synthetic PAF-acether on human neutrophil function. |
1981 |
Agents Actions |
pmid:7041568
|
de Bernardis E et al. |
Protective effects of papaverine salicylate in mouse ear dermatitis and PAF-induced rat paw oedema. |
1994 |
Agents Actions |
pmid:7847181
|
Shen TY et al. |
Recent development of platelet-activating factor antagonists. |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2546389
|
Handley DA et al. |
Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity. |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2546390
|
Dray F et al. |
Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat. |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2546391
|
Desquand S et al. |
Interference of the PAF-acether antagonist BN 52021 with anaphylaxis in the guinea pig. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2445183
|
Benveniste J |
PAF-acether (platelet-activating factor). |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2526498
|
Hsueh W and Sun XM |
Tumor necrosis factor-induced bowel necrosis: the role of platelet-activating factor. |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2526499
|
Pignol B et al. |
Effect of chronic administration of platelet-activating factor (PAF) in the guinea-pig and the rat. |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2526500
|
Foegh ML et al. |
Platelet-activating factor in organ transplant rejection. |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2526501
|
Livio M et al. |
A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2823570
|
Voelkel NF et al. |
Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221590
|
Izumi T et al. |
Regulation and signal transduction of PAF receptor. |
1995 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:7732892
|
Bennett SA and Birnboim HC |
Platelet activating factor induces transformation of human fibroblasts. |
1995 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:7732893
|
Summers JB et al. |
ABT-299, a potent antagonist of platelet activating factor. |
1995 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:7732895
|